Avixin is indicated as an adjuvant therapy for influenza vaccination in elderly patients with impaired immune function.
Dosage and Administration
The recommended dose is 900 µg/㎡ (one vial), administered subcutaneously or intramuscularly twice weekly for four weeks,
starting from the first week of influenza vaccination.
Reconstitute the lyophilized powder with the provided diluent immediately before administration.
Shelf Life
36 months from the date of manufacture.
Storage
Store in a hermetic container at 2–8°C, protected from light.